<DOC>
	<DOCNO>NCT00718289</DOCNO>
	<brief_summary>Background : A concentrate bicarbonate haemodialysis acidify citrate instead acetate market recent year . The small amount citrate use ( one-fifth concentration adopt regional anticoagulation ) protect intradialyser clotting , minimally affect calcium concentration . The aim study compare impact citrate- acetate-based dialysate systemic haemodynamics , coagulation , acid-base status , calcium balance dialysis efficiency . Methods : In 25 patient , 375 dialysis session , compare acetate ( A ) citrate dialysate ( C+ ) without ( C ) calcium supplementation ( 0.25mmol/L ) randomize single blind cross-over study . Systemic haemodynamics evaluate use pulse wave analysis system . Coagulation , acid-base status , calcium balance dialysis efficiency assess use standard biochemical marker .</brief_summary>
	<brief_title>Citrate- Versus Acetate-Based Dialysate Bicarbonate Haemodialysis : Consequences Haemodynamics , Coagulation , Acid-Base Status Electrolytes</brief_title>
	<detailed_description>Introduction : A concentrate bicarbonate haemodialysis acidify citric instead less physiologic acetic acid successfully implement United States past 7 year [ 1-3 ] . Contrarily traditional regional citrate anticoagulation , small amount citrate use acid concentrate ( 0.8 mmol/L ; one-fifth concentration necessary achieve anticoagulation [ 1,4,5 ] ) affect calcium concentration locally enhance coagulation activation limit way , result approximately 10 % reduction post-dialysis ionized calcium measurable systemic anticoagulation [ 1 ] . The absence significant systemic repercussion relate , low amount citrate use also rapid conversion citrate bicarbonate take place liver muscle determine high post-dialysis bicarbonataemia [ 1,6,7 ] . Despite rapid citrate clearance , local consequence remove calcium blood clot cascade measurable positive effect dialyser life-span `` reuse '' modality dialysis quality quantify urea Kt/V [ 1,3 ] . The improvement urea clearance correlate postulated favourable effect dialyser fibre permeability mediate intra-dialyser anticoagulant property citrate [ 1,3,8 ] . Considering importance limit biocompatibility relate coagulation activation take place extracorporeal circuit [ 9-17 ] , dispose simple way inhibit without affect systemic coagulation bleed risk [ 18 ] promising . Even thousand patient treat recent year haemodialysis fluid base citric instead acetic acid , haemodynamic tolerance ( reduction ionize calcium concentration increase bicarbonateamia could result low intra-dialytic blood pressure [ 19-25 ] ) amount systemic coagulation activation relate one modality , investigate . The aim randomize , control , single blind , cross-over study single-use dialyser bicarbonate haemodialysis , detail consequence systemic haemodynamics , coagulation activation , acid-base status , calcium balance dialysis efficiency use citric instead acetic acid haemodialysis fluid . Methods patient : Twenty-five chronic haemodialysis patient ( 15 male 10 female ) , dialyse 3 4 hour three time week , clinically stable without intercurrent illness , enrol study . Using single blind , cross-over design , patient randomize two arm study begin either traditional acetic acid ( modality A ) citric acid dialysate ( modality C ) . In follow 3 week modality weekly switch alternative one . Finally , intention compensate reduction serum calcium induced citrate binding , study arm complete week use citric acid dialysate calcium supplementation 0.25 mmol/L ( modality C+ ) . The haemodialysis perform use 4008 H machine , equip cartridge bicarbonate Bibag© , high flux single use polysulfone membrane , Fresenius Medical Care ( Bad Homburg , Germany ) . The prescribed dialyser effective surface area , dialysis fluid conductibility , temperature composition ( exception acetate [ 3.0 mmol/L A 0.3 C C+ ] , citrate [ 0 mmol/L A 0.8 C C+ ] calcium [ 1.25 1.50 mmol/L A C 1.50 1.75 C+ ] ) , effective blood flow record enrolment study , leave unchanged follow 5 week . The medication patient ( include phosphate binder ) also leave unchanged . Serum BUN , creatinine , potassium , phosphate , calcium whole blood pH , bicarbonate , ionized calcium measure begin end third dialysis session week . Ionized total calcium also measure begin end first dialysis session week . The prothrombin fragment 1+2 ( F1+2 ) thrombin-antithrombin complex ( TAT ) determine begin end third dialysis session week [ 26 ] . Blood sample take arterial limb shunt . Systolic diastolic blood pressure heart rate measure start every session , repeat 30 min interval throughout dialysis automate Blood Pressure Monitor 4008 ( Fresenius Medical Care , Bad Homburg , Germany ) integrate dialysis machine . Stroke volume ( integrated mean flow waveform current upstroke dicrotic notch ) peripheral resistance ( ratio mean arterial pressure stroke volume multiply heart rate ) evaluate 5 10 minute start session every 45 minute use finger beat-to-beat monitor Finometer© ( Finapres Medical Systems BV , Arnhem , The Netherlands ) . The use isotonic saline ( 100-200 ml ) infusion treat symptomatic hypotension symptom related intravascular hypovolaemia register . Kt/V calculate use second generation single-pool Daugirdas formula ( Kt/V = -ln ( R-0.03 ) + [ ( 4-3.5 x R ) x ( UF/W ) ] R = post-dialysis BUN/pre-dialysis BUN , UF = net ultrafiltration W = weight ) . The citrate accumulation dialysis estimate calculate calcium gap = │post-predialysis total calcium│- │post-predialysis ionized calcium│ [ 6 ] . The value 0.2 mmol/L use cut-off divide patient rapid ( &lt; 0.2 mmol/L ) slow ( ≥ 0.2 mmol/L ) metabolizers . Results express mean ± SD . Statistical analysis perform use statistical software package ( SPSS 12.0 ; SPSS Inc. , Chicago , IL , USA ) . Comparisons laboratory haemodynamic parameter do first ANOVA follow significant pair t-test perform mean value obtain patient modality . Haemodynamic parameter function dialysis time compare use trapezoidal estimation area curve follow Wilcoxon Signed Ranks test . With intention ameliorate understanding haemodynamic change , evaluation maximum increase decrease parameter add data analysis ( see Figure 2 explanation calculation method ) . Percentages compare use Fisher Exact test . In case , P ≤ 0.05 consider statistically significant ; P express n ( significant ) , =0.05 , &lt; 0.05 , &lt; 0.01 &lt; 0.001 . The protocol study approve local Ethical Committee . All patient give write informed consent prior enrolment study . References : 1 . Ahmad S , Callan R Cole JJ , Blagg CR . Dialysate make dry chemical use citric acid increase dialysis dose . Am J Kidney Dis . 2000 ; 35,493-499 . 2 . Tu A , Ahmad S. ( 2000 ) . Heparin-free hemodialysis citrate-containing dialysate intensive care patient . Neph Dial Transplant . 2000 ; 29,620-626 . 3 . Ahmad S , Callan R , Cole J , Blagg C. Increased dialyzer reuse citrate dialysate . Hemodial Int . 2005 ; 9:264-267 . 4 . Apsner R , Buchmayer H , Gruber D , Sunder-Plassmann G. Citrate long-term hemodialysis : prospective study 1,009 consecutive high-flux treatment 59 patient . Am J Kidney Dis . 2005 ; 45:557-564 . 5 . Pinnick RV , Wiegmann TB , Diederich DA . Regional citrate anticoagulation hemodialysis patient high risk bleeding . N Engl J Med . 1983 ; 308:258-61 . 6 . Bauer E , Derfler K , Joukhdar C , Druml W. Citrate kinetics patient long-term hemodialysis therapy.Am J Kidney Dis . 2005 ; 46:903-907 . 7 . Gabutti L , Marone C , Colucci G , Duchini F , Schönholzer C. Citrate anticoagulation continuous venovenous hemodiafiltration : metabolic challenge . Intensive Care Med . 2002 ; 28,1419-1425 . 8 . Gabutti L , Colucci G , Martella A , Schönholzer C , Marone C. Does monitor pre-/post-dialyzer pressure difference improve efficiency intermittent hemodialysis ? Blood Purif . 2003 ; 21,294-300 . 9 . Gabutti L , Ferrari N , Mombelli G , Keller F , Marone C. The favorable effect regional citrate anticoagulation interleukin-1beta release dissociate coagulation complement activation . J Nephrol . 2004 ; 17,819-825 . 10 . Stiekema JC . Heparin biocompatibility . Clin Nephrol . 1986 ; 26 : S3-8 . 11 . Cheung AK , Faezi-Jenkin B , Leypoldt JK . Effect thrombosis complement activation neutrophil degranulation vitro hemodialysis . J Am Soc Nephrol . 1994 ; 5:110-115 . 12 . Böhler J , Schollmeyer P , Dressel B , Dobos G , Hörl W. Reduction granulocyte activation hemodialysis regional citrate anticoagulation : dissociation complement activation neutropenia neutrophil degranulation . J Am Soc Nephrol . 1996 ; 7:234-241 . 13 . Hofbauer R , Moser D , Frass M , Oberbauer R , Kaye AD , Wagner O , Kapiotis S , Druml W. Effect anticoagulation blood membrane interaction hemodialysis . Kidney Int . 1999 ; 56:1578-1583 . 14 . Bos JC , Grooteman MP , Van Houte AJ , Schoorl M , Van Limbeek J , Nube MJ . Low polymorphonuclear cell degranulation citrate anticoagulation : comparison citrate heparin dialysis . Nephrol Dial Transplant . 1997 ; 12:1387-1393 . 15 . Dhondt A , Vanholder R , Tielemans C , Glorieux G , Waterloos MA , De Smet R , Lameire N. Effect regional citrate anticoagulation leukopenia , complement activation expression leukocyte surface molecule hemodialysis unmodified cellulose membrane . Nephron . 2000 ; 85:334-342 . 16 . Bartels PC , Schoorl M , Wiering JG , Nube MJ . Activation coagulation treatment hemodialysis . Scand J Clin Lab Invest . 2000 ; 60:283-290 . 17 . Wiegmann TB , McDougall ML , Diederich DA . Dialysis leukopenia , hypoxemia anaphylatoxin formation : effect membrane , bath citrate anticoagulation . Am J Kidney Dis 1988 ; 11:418-424 . 18 . Fischer KG . Essentials anticoagulation hemodialysis.Hemodial Int . 2007 ; 11:178-189 . 19 . Kaye M , Vasilevsky M , Ketis M. The effect blood pressure acute fall ionized calcium hemodialysis . A randomized study two patient . Clin Nephrol . 1998 ; 50:361-366 . 20 . Van der Sande FM , Cheriex EC , Van Kuijk WHM , Leunissen KML . Effect dialysate calcium concentration intradialytic blood pressure course cardiac-compromised patient . Am J Kidney Dis . 1998 ; 32:125-131 . 21 . Leunissen KML , Van den Berg BW , van Hooff JP . Ionized calcium play pivotal role control blood pressure haemodialysis . Blood Purif . 1989 ; 7:233-239 . 22 . Sherman RA , Bialy GB , Gazinski B , Bernholc AS , Eisinger RP . The effect dialysate calcium level blood pressure hemodialysis . Am J Kidney Dis . 1986 ; 8:244-247 . 23 . Maynard JC , Cruz C , Kleerekoper M , Levin NW . Blood pressure response change serum ionized calcium hemodialysis . Ann Intern Med . 1986 ; 104:358-361 . 24 . Gabutti L , Ross V , Duchini F , Mombelli G , Marone C. Does Bicarbonate transfer relevant hemodynamic consequence standard hemodialysis ? Blood Purif . 2005 ; 23:365-372 . 25 . Gabutti L , Ferrari N , Giudici G , Mombelli G , Marone C. Unexpected haemodynamic instability associate standard bicarbonate haemodialysis . Nephrol Dial Transplant . 2003 ; 18:2369-2376 . 26 . Nossel HL , Yudelman I , Canfield RE , Butler VP , Spanondis K , Wilner GD , Qureshi GD . Measurement fibrinopeptide A human blood . J Clin Invest . 1974 ; 54:43-53 .</detailed_description>
	<mesh_term>Dialysis Solutions</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>chronic haemodialysis patient dialyse 3 4 hour three time week , clinically stable without intercurrent illness intercurrent illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Citric acid</keyword>
	<keyword>citrate</keyword>
	<keyword>acetic acid</keyword>
	<keyword>acetate</keyword>
	<keyword>haemodialysis</keyword>
	<keyword>calcium</keyword>
	<keyword>hypotension</keyword>
	<keyword>haemodynamics</keyword>
	<keyword>Dialysate Haemodialysis</keyword>
</DOC>